Drug Profile
Research programme: metabolic disorders therapy - Particle Therapeutics
Alternative Names: PRT 001; PRT 003Latest Information Update: 18 Dec 2015
Price :
$50
*
At a glance
- Originator Particle Therapeutics
- Class Pancreatic hormones
- Mechanism of Action Glucagon receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Hypoglycaemia
Most Recent Events
- 18 Dec 2015 Discontinued - Preclinical for Hypoglycaemia in United Kingdom (Injection)
- 30 Aug 2007 Early research in Hypoglycaemia treatment in United Kingdom (Injection, Powder)